Geode Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,246,527
Closed -$723K 4575
2024
Q3
$723K Buy
1,246,527
+200,857
+19% +$113K ﹤0.01% 3468
2024
Q2
$646K Sell
1,045,670
-942,122
-47% -$796K ﹤0.01% 3476
2024
Q1
$5.11M Buy
1,987,792
+82,019
+4% +$200K ﹤0.01% 2696
2023
Q4
$3.89M Buy
1,905,773
+138,674
+8% +$253K ﹤0.01% 2828
2023
Q3
$3.04M Buy
1,767,099
+91,041
+5% +$162K ﹤0.01% 2895
2023
Q2
$3.27M Buy
1,676,058
+931,478
+125% +$2.18M ﹤0.01% 2922
2023
Q1
$2.07M Buy
744,580
+32,612
+5% +$93.2K ﹤0.01% 3012
2022
Q4
$2.46M Buy
711,968
+107,118
+18% +$306K ﹤0.01% 2964
2022
Q3
$1.55M Sell
604,850
-915
-0.2% -$2.91K ﹤0.01% 3180
2022
Q2
$1.47M Sell
605,765
-257,785
-30% -$677K ﹤0.01% 3238
2022
Q1
$3.56M Sell
863,550
-4,178
-0.5% -$22.1K ﹤0.01% 2972
2021
Q4
$11.2M Buy
867,728
+159,660
+23% +$1.77M ﹤0.01% 2372
2021
Q3
$7.65M Buy
708,068
+173,972
+33% +$1.58M ﹤0.01% 2660
2021
Q2
$4.88M Buy
534,096
+94,864
+22% +$877K ﹤0.01% 2927
2021
Q1
$4.14M Buy
439,232
+22,219
+5% +$306K ﹤0.01% 2881
2020
Q4
$1.64M Buy
417,013
+11,291
+3% +$34.1K ﹤0.01% 3186
2020
Q3
$1.07M Buy
405,722
+16,790
+4% +$62.3K ﹤0.01% 3186
2020
Q2
$2.58M Buy
388,932
+59,356
+18% +$400K ﹤0.01% 2706
2020
Q1
$1.92M Buy
329,576
+22,034
+7% +$185K ﹤0.01% 2690
2019
Q4
$2.76M Buy
307,542
+19,873
+7% +$166K ﹤0.01% 2804
2019
Q3
$2.48M Buy
287,669
+3,534
+1% +$35.7K ﹤0.01% 2804
2019
Q2
$3.17M Buy
284,135
+180,189
+173% +$2.06M ﹤0.01% 2657
2019
Q1
$1.38M Buy
103,946
+15,368
+17% +$205K ﹤0.01% 3027
2018
Q4
$1.37M Buy
+88,578
New +$1.69M ﹤0.01% 2969

Other funds holding GRTS

Geode Capital Management's GRTS Position: Q4 2024 in Review

Geode Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 1,246,527 shares — an estimated $723K sold.

Geode Capital Management first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $11.2M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Geode Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 1,246,527 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $723K.
  • Geode Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Geode Capital Management's Gritstone bio, Inc. Common Stock position peaked at $11.2M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.